Wellness

  • Ovum and AKQA announce strategic partnership

    Femtech app Ovum has agreed a strategic partnership with creative agency AKQA Australia to support growth and boost consumer adoption. The collaboration will see AKQA develop creative concepts across digital, PR and social channels, with a major brand moment planned for International Women’s Day 2026. Founded by Dr Ariella Heffernan-Marks, a former medical doctor turned [...]

  • Uterine fibroids linked to increased heart disease risk

    Long-term heart disease risk among women with uterine fibroids is more than 80 per cent higher than in those without, according to a new study. Fibroids are predominantly benign growths that develop from the muscle tissue of the uterus. Study author Julia D. DiTosto is a PhD candidate in epidemiology at the Perelman [...]

  • Ten FemTech innovations join UK Evaluate programme

    Ten FemTech innovations have been chosen for Accelerating FemTech: Evaluate, led by Health Innovation South London and DigitalHealth.London with UK partners. The accelerator, part of the Innovate UK Biomedical Catalyst, supports women’s health solutions at technology readiness level 4 or higher, meaning prototypes proven in a lab or relevant setting and preparing for market entry. [...]

  • Intermountain partners with Testmate on STI tests

    Intermountain Health has partnered with Testmate Health, investing to expand access to rapid, low-cost STI tests in at-risk communities beyond traditional labs. STIs often go undetected, with an estimated 80 per cent of chlamydia and gonorrhoea infections missed each year. Testmate’s single-use, reader-free molecular tests for Chlamydia trachomatis and Neisseria gonorrhoeae deliver results in under [...]

  • MyBliss secures backing from women-led angel groups

    MyBliss has secured investment from women-led angel groups to scale science-led intimacy care and women’s health research. The company, founded after co-founder Mo Carrier’s experience with hormonal contraception side effects, centres products on women’s bodies and needs. Its flagship MyBliss Ultra-Thin Condoms were developed using gynaecologist-informed criteria and strict formulation standards. The condoms are vegan-certified [...]

  • Joi + Blokes acquires HerMD for US virtual care

    Joi + Blokes acquires HerMD, creating a virtual women’s health platform serving all 50 US states after HerMD’s shift to online-only care in spring 2025. HerMD relaunched as a virtual-only platform in spring 2025 after closing its physical sites in March 2025. Financial terms were not disclosed. The company had previously raised about US$30m, including [...]

  • Acceptable use vs exploitation with ‘free’ digital health tools

    By Wolfgang Hackl, CEO, OncoGenomX Inc., Allschwil, Switzerland “Free” digital health tools are rarely free. In most cases the user – healthy or patient - pay with something far more valuable than a subscription fee: intimate, high-granularity data about their bodies, behaviours, and vulnerabilities. As digital health platforms grow into critical infrastructure for care, research [...]

  • Human Health raises £4.1m for precision care

    Human Health has raised £4.1m seed funding to expand its precision health platform for patients with chronic conditions and accelerate UK rollout. The company’s “Precision Health OS” is an operating system-style platform that uses patient-reported data and AI to tailor care. Patients can track symptoms, treatments and routines, detect patterns and share doctor-ready reports. More [...]

  • Canada targets US$37bn femtech opportunity

    Vancouver forum brings policy, industry and health leaders together to tap Canada's US$37bn femtech opportunity. The 2025 Femtech Canada Forum brought together representatives from policy, academia, industry and global health organisations to address what organisers describe as a US$37bn economic opportunity for Canada's economy through women's health technology. Femtech Canada announced it will join the [...]

  • Five ideas shaping the future of women’s health: Insights from Women’s Health Week Europe 2025

    By Femi Adetoro, marketing manager, Women’s Health Week Women’s Health Week Europe 2025 brought 400 investors, innovators, corporates, clinicians, and policymakers together at the beautiful Barbican Centre in London for three days of big thinking and real partnership-building. This was my first Women’s Health Week, and over a month later, the conversations are still shaping [...]